Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Onkure Therapeutics Inc OKUR

Healthcare Biotechnology
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the... see more

Recent & Breaking News (NDAQ:OKUR)

Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm

PR Newswire July 1, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, RPHM, VAPO on Behalf of Shareholders

ACCESS Newswire June 26, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALE, RPHM, SQSP on Behalf of Shareholders

PR Newswire June 24, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

PR Newswire June 24, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Continues to Investigate PRFT, SBOW, RPHM, AGR

PR Newswire May 30, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPHM, WIRE, BCAL, AIRC

PR Newswire May 23, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SBOW, PRFT, RPHM

PR Newswire May 20, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALE, RPHM, AGS

PR Newswire May 16, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPHM, ALE, HRT

ACCESS Newswire May 15, 2024

SHAREHOLDER ALERT: Halper Sadeh LLC Continues to Investigate SQSP, RPHM, ALE, HRT

ACCESS Newswire May 14, 2024

RENEO PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Reneo Pharmaceuticals, Inc. - RPHM

Business Wire May 14, 2024

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Reneo Pharmaceuticals, Inc. - RPHM

PR Newswire May 13, 2024

Lifshitz Law PLLC Announces Investigations of RPHM, SQSP, AGS, and LSAK

ACCESS Newswire May 13, 2024

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Reneo Pharmaceuticals, Inc. Merger

Newsfile May 13, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, RPHM

PR Newswire May 13, 2024

Shareholder Alert: Ademi LLP investigates whether Reneo Pharmaceuticals, Inc. has obtained a Fair Price in its Transaction with OnKure

PR Newswire May 13, 2024

RPHM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Reneo Pharmaceuticals, Inc. Is Fair to Shareholders

Business Wire May 13, 2024

Reneo Pharmaceuticals and OnKure Announce Proposed Merger

GlobeNewswire May 13, 2024

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire May 7, 2024

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update

GlobeNewswire March 28, 2024

Podcasts